| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.27 | 2e-12 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-10 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |